#MedicareCOVID19VaccineAnalysis | #CMS

Medicare COVID-19 Vaccine Analysis in December of 2020, the first COVID-19 vaccine received emergency use authorization (EUA).  Following the EUA, CMS began to assess the feasibility of using Medicare claims data (i.e., fee-for-service claims) to track the administration of the COVID-19 vaccine among the Medicare population.  CMS is releasing two resources with information on COVID-19 vaccine administration claims among Medicare beneficiaries.

Source: Medicare COVID-19 Vaccine Analysis | CMS